Inactief instrument

Andere talen NovAccess Global Inc. Other OTC

Aandelen

XSNX

US67001N1072

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

NovAccess Global : Material Agreement Form 8 K	04/06
NovAccess Global Inc. announced that it has received $0.009 million in funding	31/05
NovAccess Global Inc. Files Patent with Cedars-Sinai to Advance Its Brain Cancer Fighting Vaccine Platform	21/05
NovAccess Global Inc. acquired 18.60% stake in Fendix Media Ltd from David Sumner for $0.12 million.	17/05
NovAccess Global Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024	15/05
NovAccess Global Inc. announced that it has received $0.1053 million in funding from AJB Capital Investments LLC	13/05
NovAccess Global : Announces New License to Advance its Immunotherapy Platform	30/04
NovAccess Global Inc. announced that it has received $0.0265 million in funding from AJB Capital Investments LLC	29/04
NovAccess Global Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023	27/02
NovAccess Global Inc. announced that it has received $0.1 million in funding from AJB Capital Investments LLC	27/02
NovAccess Global Inc. Reports Earnings Results for the Full Year Ended September 30, 2023	09/02
NovAccess Global Announces $10.7 Million Financing	03/01
NovAccess Global Inc. to Present at the December 7th Virtual Investor Summit	01/12
NovAccess Global Inc. Appoints Roscoe M. Moore, Jr. to Scientific Advisory Board	10/11
NovAccess Global Inc. announced that it expects to receive $10.68 million in funding from Sumner Capital Pty Ltd.	01-09-23
NovAccess Global Inc. announced that it expects to receive $0.055 million in funding	16-08-23
NovAccess Global Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2023	11-08-23
NovAccess Global Partners with BCN Biosciences to Expand Immunotherapy Platform	28-07-23
NovAccess Global Inc. Partners with BCN Biosciences to Expand Immunotherapy Platform	27-07-23
NovAccess Global : to Participate in National Brain Tumor Society’s Annual Glioblastoma Awareness Day	13-07-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen NovAccess Global Inc. Other OTC

Aandelen

XSNX

US67001N1072

Andere talen

Filters